|
AEVIS VICTORIA SA / Key word(s): Miscellaneous Ad hoc announcement pursuant to Art. 53 LR Fribourg, 23 May 2023 AEVIS VICTORIA SA (AEVS:SW) – Increased revenues for the operational divisions, positive outlook for the current fiscal year. Organic growth of 9.2% in the first quarter 2023. AEVIS VICTORIA SA’s (AEVIS) consolidated revenues for the first quarter of 2023 amounted to CHF 263.0 million (Q1 2022: CHF 316.3m), down mainly due to the deconsolidation of Réseau de l’Arc as of 31.12.2022 and the absence of M&A transactions. With a 9.2% organic revenue growth, Swiss Medical Network and Victoria-Jungfrau, the operating divisions of AEVIS, performed strongly during the first quarter of 2023. Growth continues during the second quarter and the group expects an overall good year 2023. Swiss Medical Network SA achieved revenues of CHF 203.6 million (Q1 2022: CHF 193.6m on a like-for-like basis), with a 5% organic growth. Réseau de l’Arc SA, a now 35.1% participation of Swiss Medical Network, was deconsolidated as of 31.12.2022 following the entry in the share capital of Visana Beteiligungen AG. Victoria-Jungfrau AG pursued its growth with consolidated revenues up by 36.4% to CHF 56.3 million (Q1 2022: CHF 41.3m), driven by a 30% organic growth. The 2022 acquisitions of Hotel Adula in Flims and L’Oscar in London contributed CHF 2.7 million to the increase. For further information: AEVIS VICTORIA SA - Investing for a better life End of Inside Information |
1638727 23-May-2023 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
Special
